SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

14 Feb 2026 Evaluate
The Sales for the quarter ended December 2025 of Rs. 1924.14 million declined by -39.57% from Rs. 3183.82 millions.A big decline of -59.42% was reported for the quarter ended December 2025 to Rs. 401.66  millions from Rs. 989.83 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 600.99 millions from 1372.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1924.14 3183.82 -39.57 7126.53 6895.41 3.35 10299.85 7115.98 44.74
Other Income 132.09 132.41 -0.24 457.34 340.30 34.39 462.56 288.60 60.28
PBIDT 600.99 1372.55 -56.21 2685.67 2717.93 -1.19 4239.86 2580.90 64.28
Interest 3.39 0.16 2018.75 56.56 0.64 8737.50 0.98 1.61 -39.13
PBDT 597.60 1372.39 -56.46 2629.11 2717.29 -3.25 4238.88 2481.86 70.79
Depreciation 59.83 47.45 26.09 175.47 128.42 36.64 177.89 280.91 -36.67
PBT 537.77 1324.94 -59.41 2453.64 2588.87 -5.22 4060.99 2200.95 84.51
TAX 136.11 335.11 -59.38 618.92 637.78 -2.96 1008.96 563.44 79.07
Deferred Tax 16.21 10.11 60.34 21.92 37.78 -41.98 41.21 21.44 92.21
PAT 401.66 989.83 -59.42 1834.72 1951.09 -5.96 3052.03 1637.51 86.38
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 31.23 43.11 -27.55 37.69 39.42 -4.39 41.16 36.27 13.50

Blue Jet Healthcare Share Price

491.25 2.85 (0.58%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×